Cargando…

Predicting Early Viral Control under Direct-Acting Antiviral Therapy for Chronic Hepatitis C Virus Using Pretreatment Immunological Markers

Recent introduction of all-oral direct-acting antiviral (DAA) treatment has revolutionized care of patients with chronic hepatitis C virus (HCV) infection. Regrettably, the high cost of DAA treatment is burdensome for healthcare systems and may be prohibitive for some patients who would otherwise be...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hutchinson, James A., Weigand, Kilian, Adenugba, Akinbami, Kronenberg, Katharina, Haarer, Jan, Zeman, Florian, Riquelme, Paloma, Hornung, Matthias, Ahrens, Norbert, Schlitt, Hans J., Geissler, Edward K., Werner, Jens M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2018
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5808305/ https://www.ncbi.nlm.nih.gov/pubmed/29467758 http://dx.doi.org/10.3389/fimmu.2018.00146

Ejemplares similares

Immunomodulation of Natural Killer Cell Function by Ribavirin Involves TYK-2 Activation and Subsequent Increased IFN-γ Secretion in the Context of In Vitro Hepatitis E Virus Infection
por: Kupke, Paul, et al.
Publicado: (2023)

Development of a Flow Cytometry Assay to Predict Immune Checkpoint Blockade-Related Complications
por: Schilling, Hannah-Lou, et al.
Publicado: (2021)

In question: the scientific value of preclinical safety pharmacology and toxicology studies with cell-based therapies
por: Broichhausen, Christiane, et al.
Publicado: (2014)

TIGIT(+) iTregs elicited by human regulatory macrophages control T cell immunity
por: Riquelme, Paloma, et al.
Publicado: (2018)

Laser Ablation Inductively Coupled Plasma Mass Spectrometry: An Emerging Technology for Multiparametric Analysis of Tissue Antigens
por: Hutchinson, Robert W., et al.
Publicado: (2015)

External validation of biomarkers for immune-related adverse events after immune checkpoint inhibition
por: Glehr, Gunther, et al.
Publicado: (2022)

Immune profile of patients with peritoneal carcinomatosis selected for CRS-HIPEC therapy
por: Kleber, Julia, et al.
Publicado: (2023)

Alternative approaches to myeloid suppressor cell therapy in transplantation: comparing regulatory macrophages to tolerogenic DCs and MDSCs
por: Riquelme, Paloma, et al.
Publicado: (2012)

Postoperative cellular stress in the kidney is associated with an early systemic γδ T-cell immune cell response
por: Göcze, Ivan, et al.
Publicado: (2018)

DHRS9 Is a Stable Marker of Human Regulatory Macrophages
por: Riquelme, Paloma, et al.
Publicado: (2017)

High normal values of circulating immune cell subsets before surgery may be protective against development of postoperative acute kidney injury
por: Ehehalt, K, et al.
Publicado: (2015)

Virus-specific memory T cell responses unmasked by immune checkpoint blockade cause hepatitis
por: Hutchinson, James A., et al.
Publicado: (2021)

DX5(+)NKT cells display phenotypical and functional differences between spleen and liver as well as NK1.1(-)Balb/c and NK1.1(+ )C57Bl/6 mice
por: Werner, Jens M, et al.
Publicado: (2011)

Murine DX5(+)NKT Cells Display Their Cytotoxic and Proapoptotic Potentials against Colitis-Inducing CD4(+)CD62L(high) T Cells through Fas Ligand
por: Werner, Jens M., et al.
Publicado: (2018)

Identification and Isolation of Type II NKT Cell Subsets in Human Blood and Liver
por: Yang Zhou, Jordi, et al.
Publicado: (2022)

Negative pressure wound therapy (NPWT) on closed incisions to prevent surgical site infection in high-risk patients in hepatopancreatobiliary surgery: study protocol for a randomized controlled trial—the NP-SSI trial
por: Brennfleck, Frank W., et al.
Publicado: (2020)

Rapid Decline of Serum Proprotein Convertase Subtilisin/Kexin 9 (PCSK9) in Non-Cirrhotic Patients with Chronic Hepatitis C Infection Receiving Direct-Acting Antiviral Therapy
por: Grimm, Jonathan, et al.
Publicado: (2021)

Immunological Predictors of Nonresponse to Directly Acting Antiviral Therapy in Patients With Chronic Hepatitis C and Decompensated Cirrhosis
por: Childs, Kate, et al.
Publicado: (2017)

Immunological Dynamics Associated with Direct-Acting Antiviral Therapies in Naive and Experimented HCV Chronic-Infected Patients
por: Pereira, Grenda Leite, et al.
Publicado: (2019)

HCV Cure With Direct-Acting Antivirals Improves Liver and Immunological Markers in HIV/HCV-Coinfected Patients
por: Brochado-Kith, Óscar, et al.
Publicado: (2021)

Immunological Mechanisms for Hepatocellular Carcinoma Risk after Direct-Acting Antiviral Treatment of Hepatitis C Virus Infection
por: Sung, Pil Soo, et al.
Publicado: (2021)

Evolution of Pretreatment Assessment and Direct Acting Antiviral Regimens in Accordance with Upgrading Guidelines: A Retrospective Study in HIV/HCV Coinfected Patients †
por: Henry, Zachary, et al.
Publicado: (2018)

Prioritization of HCV treatment in the direct-acting antiviral era: An economic evaluation
por: Martin, Natasha K., et al.
Publicado: (2016)

Immunology Guides Skeletal Muscle Regeneration
por: Sass, F. Andrea, et al.
Publicado: (2018)

ALPPS (associating liver partition and portal vein ligation for staged hepatectomy) does not affect proliferation, apoptosis, or angiogenesis as compared to standard liver resection for colorectal liver metastases
por: Joechle, Katharina, et al.
Publicado: (2017)

Multitarget Direct‐Acting Antiviral Therapy Is Associated With Superior Immunologic Recovery in Patients Coinfected With Human Immunodeficiency Virus and Hepatitis C Virus
por: Shrivastava, Shikha, et al.
Publicado: (2018)

HIV/HCV Antiviral Drug Interactions in the Era of Direct-acting Antivirals
por: Rice, Donald P., et al.
Publicado: (2016)

The ‘Viennese epidemic’ of acute HCV in the era of direct‐acting antivirals
por: Chromy, David, et al.
Publicado: (2022)

Long-acting antiviral agents for HIV treatment
por: Margolis, David A., et al.
Publicado: (2015)

Influenza Antiviral Subversion: Now the Host Is in on the Act
por: Yepsen, Erin N., et al.
Publicado: (2021)

Timing of Closure of a Protective Loop-Ileostomy Can Be Crucial for Restoration of a Functional Digestion
por: Werner, Jens M., et al.
Publicado: (2022)

Antiviral and immunological activity of zinc and possible role in COVID-19
por: Marreiro, Dilina do Nascimento, et al.
Publicado: (2021)

Tolloid-like 1 gene variant rs17047200, pretreatment FIB-4, ALBI and PALBI scores as predictors of hepatocellular carcinoma occurrence after directly acting antivirals
por: Kamal, Ahmed, et al.
Publicado: (2022)

Direct Acting Antivirals for the Treatment of Chronic Viral Hepatitis
por: Karayiannis, Peter
Publicado: (2012)

Direct-acting antiviral retreatment patterns for hepatitis C
por: Hasan, Shaquib Al, et al.
Publicado: (2022)

Editorial: Immunological Tolerance in Transplantation: More Than Deletion
por: Pilat, Nina, et al.
Publicado: (2022)

Calcium-sensing receptor acts as an antiviral factor for rotavirus infections and participates in cellular antiviral response
por: Huang, Haohai, et al.
Publicado: (2022)

Direct-acting antivirals-based therapy decreases hepatic fibrosis serum biomarker microfibrillar-associated protein 4 in hepatitis C patients
por: Mölleken, Christian, et al.
Publicado: (2019)

Targeting cMET with INC280 impairs tumour growth and improves efficacy of gemcitabine in a pancreatic cancer model
por: Brandes, Franziska, et al.
Publicado: (2015)

Increased cytoplasmatic expression of cancer immune surveillance receptor CD1d in anaplastic thyroid carcinomas
por: Weber, Florian, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_oi6jec5fb1kbmcmostulsq86ba